BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 24769175)

  • 1. Relationship of vitamin D insufficiency to AIDS-associated Kaposi's sarcoma outcomes: retrospective analysis of a prospective clinical trial in Zimbabwe.
    Erlandson KM; Gudza I; Fiorillo S; Ndemera B; Schooley RT; Gwanzura L; Borok M; Campbell TB
    Int J Infect Dis; 2014 Jul; 24():6-10. PubMed ID: 24769175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of plasma human herpesvirus 8 DNA as a marker of clinical outcomes during antiretroviral therapy for AIDS-related Kaposi sarcoma in Zimbabwe.
    Borok M; Fiorillo S; Gudza I; Putnam B; Ndemera B; White IE; Gwanzura L; Schooley RT; Campbell TB
    Clin Infect Dis; 2010 Aug; 51(3):342-9. PubMed ID: 20572760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposi's sarcoma.
    Lebbé C; Blum L; Pellet C; Blanchard G; Vérola O; Morel P; Danne O; Calvo F
    AIDS; 1998 May; 12(7):F45-9. PubMed ID: 9619797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete remission of AIDS/Kaposi's sarcoma after treatment with a combination of two nucleoside reverse transcriptase inhibitors and one non-nucleoside reverse transcriptase inhibitor.
    Murdaca G; Campelli A; Setti M; Indiveri F; Puppo F
    AIDS; 2002 Jan; 16(2):304-5. PubMed ID: 11807324
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term clinical outcome of AIDS-related Kaposi's sarcoma during highly active antiretroviral therapy.
    Cattelan AM; Calabrò ML; De Rossi A; Aversa SM; Barbierato M; Trevenzoli M; Gasperini P; Zanchetta M; Cadrobbi P; Monfardini S; Chieco-Bianchi L
    Int J Oncol; 2005 Sep; 27(3):779-85. PubMed ID: 16077928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AIDS-associated Kaposi sarcoma: outcomes after initiation of antiretroviral therapy at a university-affiliated hospital in urban Zimbabwe.
    Nelson BC; Borok MZ; Mhlanga TO; Makadzange AT; Campbell TB
    Int J Infect Dis; 2013 Oct; 17(10):e902-6. PubMed ID: 23809198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term efficacy on Kaposi's sarcoma of highly active antiretroviral therapy in a cohort of HIV-positive patients. CISIH 92. Centre d'information et de soins de l'immunodéficience humaine.
    Dupont C; Vasseur E; Beauchet A; Aegerter P; Berthé H; de Truchis P; Zucman D; Rouveix E; Saiag P
    AIDS; 2000 May; 14(8):987-93. PubMed ID: 10853980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II trial of imatinib in AIDS-associated Kaposi's sarcoma: AIDS Malignancy Consortium Protocol 042.
    Koon HB; Krown SE; Lee JY; Honda K; Rapisuwon S; Wang Z; Aboulafia D; Reid EG; Rudek MA; Dezube BJ; Noy A
    J Clin Oncol; 2014 Feb; 32(5):402-8. PubMed ID: 24378417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective stage-stratified approach to AIDS-related Kaposi's sarcoma.
    Bower M; Dalla Pria A; Coyle C; Andrews E; Tittle V; Dhoot S; Nelson M
    J Clin Oncol; 2014 Feb; 32(5):409-14. PubMed ID: 24378415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clearance of human herpesvirus type 8 viraemia in HIV-1-positive patients with Kaposi's sarcoma treated with liposomal doxorubicin. Caelyx/KS Spanish Study Group.
    Núñez M; Machuca A; Soriano V; Podzamczer D; González-Lahoz J
    AIDS; 2000 May; 14(8):913-9. PubMed ID: 10853972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired immunodeficiency syndrome-related Kaposi's sarcoma regression after highly active antiretroviral therapy: biologic correlates of clinical outcome.
    Cattelan AM; Calabrò ML; Gasperini P; Aversa SM; Zanchetta M; Meneghetti F; De Rossi A; Chieco-Bianchi L
    J Natl Cancer Inst Monogr; 2001; (28):44-9. PubMed ID: 11158206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to liposomal doxorubicin and clinical outcome of HIV-1-infected patients with Kaposi's sarcoma receiving highly active antiretroviral therapy.
    Núñez M; Saballs P; Valencia ME; Santos J; Ferrer E; Santos I; Berrocal A; Galindo MJ; Podzamczer D; Gonzlez-Lahoz J;
    HIV Clin Trials; 2001; 2(5):429-37. PubMed ID: 11673818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regression of AIDS-related Kaposi's sarcoma associated with clearance of human herpesvirus-8 from peripheral blood mononuclear cells following initiation of antiretroviral therapy.
    Wit FW; Sol CJ; Renwick N; Roos MT; Pals ST; van Leeuwen R; Goudsmit J; Reiss P
    AIDS; 1998 Jan; 12(2):218-9. PubMed ID: 9468373
    [No Abstract]   [Full Text] [Related]  

  • 14. Predictors of immune reconstitution inflammatory syndrome-associated with kaposi sarcoma in mozambique: a prospective study.
    Letang E; Almeida JM; Miró JM; Ayala E; White IE; Carrilho C; Bastos R; Nhampossa T; Menéndez C; Campbell TB; Alonso PL; Naniche D
    J Acquir Immune Defic Syndr; 2010 Apr; 53(5):589-97. PubMed ID: 19801945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
    Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
    AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete regression of AIDS-related Kaposi's sarcoma in a child treated with highly active antiretroviral therapy.
    Niehues T; Horneff G; Megahed M; Schroten H; Wahn V
    AIDS; 1999 Jun; 13(9):1148-9. PubMed ID: 10397553
    [No Abstract]   [Full Text] [Related]  

  • 17. Regression of AIDS-related Kaposi's sarcoma following combined antiretroviral treatment.
    Monticelli A; Lewi D; Salomon H; Pampuro S; Libonatti O; Jauregui Rueda H; Hodara V
    Rev Argent Microbiol; 2000; 32(4):206-8. PubMed ID: 11149154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the human herpesvirus 8 DNA load in blood and Kaposi's sarcoma skin lesions from AIDS patients on highly active antiretroviral therapy.
    Boivin G; Gaudreau A; Routy JP
    AIDS; 2000 Sep; 14(13):1907-10. PubMed ID: 10997393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do we still need chemotherapy for AIDS-associated Kaposi's sarcoma?
    Dalla Pria A; Hayward K; Bower M
    Expert Rev Anticancer Ther; 2013 Feb; 13(2):203-9. PubMed ID: 23406561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy for AIDS-related and endemic African Kaposi's sarcoma in southern Africa.
    Stein ME; Lachter J; Spencer D; Bezwoda WR
    Int J Dermatol; 1995 Oct; 34(10):729-32. PubMed ID: 8537166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.